BRIEF—Spark Therapeutics adding 500 new jobs in Philadelphia

Spark Therapeutics, a commercial gene therapy company, is moving to the Schuylkill Yards development in University City, Philadelphia.

This move will create 500 new jobs in addition to its current 262 employees. This move will allow the company to expand their research and development operations, reports the Select Greater Philadelphia Council.

“This expansion is proof of our continued commitment to research, development, and innovation in West Philadelphia and of our determination to offer new genetic treatments for people living with genetic diseases,” said Spark chief executive and co-founder Jeffrey Marrazzo.

The company received DCED funding for their expansion from a $2 billion Pennsylvania First grant for their projected job growth and a $7.5 million grant from the Redevelopment Assistance Capital Program.